Evidence map›Paper›PMID 42780441›Full record

SynthesisFrontiers in aging neuroscience2026

Sleep-neuroinflammation interactions in Alzheimer's disease: a systematic review of biomarker pathways.

Alberto Cordella, Athina Bruschetti-Thomi, Leonardo Sacco, Claudio Liguori

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alberto CordellaMemory Clinic, Department of Neurology, Neurocenter of Southern Switzerland, Régional Hospital of Lugano, Lugano, Switzerland.
Athina Bruschetti-ThomiRegional Hospital of Lugano, Internal Medicina, Lugano, Switzerland.
Leonardo SaccoMemory Clinic, Department of Neurology, Neurocenter of Southern Switzerland, Régional Hospital of Lugano, Lugano, Switzerland.
Claudio LiguoriNeurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although sleep disturbances are increasingly associated with Alzheimer's disease (AD), the mechanistic interplay between sleep physiology, neuroinflammation and AD-related pathology is not fully understood. The question of whether disrupted sleep contributes to neurodegeneration or merely reflects early pathological processes is still being debated. In accordance with PRISMA-2020 guidelines, we conducted a systematic review to synthesize the current evidence linking objectively measured sleep alterations, glial activation and AD-related outcomes. A comprehensive search of PubMed, Scopus, EMBASE and Web of Science (January 2000 - June 2026) identified 40 original studies that met the predefined inclusion criteria. These studies included objective sleep assessments (polysomnography, electroencephalography, actigraphy, or experimental sleep manipulation), direct evaluations of neuroinflammatory or glial markers, and assessments of amyloid-

Indexed as

Alzheimer’s diseaseastrocytesbiomarkerscircadian rhythmsglymphatic systemmicroglianeuroinflammation

Identifiers

PMID42780441
PMCPMC13597314

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.